Cannabis Stock News Daily Roundup May 23

Everest BioPharma International received approval from Health Canada to complete the build-out of its cannabis extraction systems in its plant in Kelowna, B.C. The first sales of full spectrum cannabis oil are expected in September 2019.

Story continues below

Aurora Cannabis (NYSE: ACB) (TSX: ACB) has formed a partnership with mixed martial arts organization UFC to advance further clinical research on the relationship between 100% hemp derived cannabidiol products and athlete wellness and recovery. The research will be conducted at the UFC’s Performance Institute in Las Vegas, Nevada, in collaboration with UFC’s sports performance team, as well as with athletes who choose to participate in the studies.

Garden Remedies, Massachusetts’ only cannabis company founded and led by a woman physician, said that its Newton dispensary, located at 697 Washington St., received its final approval from the Massachusetts Cannabis Control Commission to commence adult use sales. The company plans to begin adult use cannabis sales starting from May 25.

Mike Tyson’s cannabis venture, Tyson Ranch, has formed a new partnership with Big Foot Management, a California based cannabis technology company that develops novel technologies and specializes in producing water-soluble formats of cannabis. Big Foot will initially utilize its nano technologies to develop Tyson’s new CBD beverage line, Dwiink, which will be infused with Big Foot’s tasteless and odorless water-soluble CBD. Dwiink is expected to be available in major retailers across the U.S. soon.

Canopy Rivers (TSXV: RIV) (OTC: CNPOF) said that its portfolio company Agripharm Corp. has received its outdoor cultivation license from Health Canada. Agripharm will be growing its first outdoor crop this summer at its Creemore, Ontario, location using award-winning genetics.

Australis Capital (CSE: AUSA) (OTC: AUSAFhas entered into an asset purchase agreement with Green Therapeutics and affiliated companies, to acquire its Tsunami, Provisions, and GT Flowers cannabis brands, certain operating assets, intellectual property and the right to assume, complete and expand the construction of a state-of-the-art 55,000-square-foot cultivation and production facility in North Las Vegas, Nevada. The acquisition also includes GT’s experienced operating team.

Canopy Growth (TSX: WEED) (NYSE: CGC) has named Mike Lee as the acting chief financial officer, effective June 1. Mike’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all officers and directors of the company.

Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQX: CTABF) (FRA: TBF1.F) has received a cultivation license for industrial hemp from Health Canada. The company now plans to secure a substantial amount of hemp biomass that it will grow and cultivate for the extraction of cannabidiol and conduct research on high CBD hemp varieties. In addition, the company intends to use part of this CBD oil in its manufacturing of its suite of cannabis hard pills.

Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF) has acquired exclusive rights to operate the Emerald dispensary in Gilbert, Arizona. The dispensary’s license is held by Absolute Healthcare, an Arizona non-profit corporation. The dispensary will be rebranded as Curaleaf after the deal closes.

Choom Holdings (CSE: CHOO) (OTCQB: CHOOFannounced that Specialty Medijuana Products, in which Choom has a 9.8% equity stakeholder, has received a cultivation license on an additional and contiguous site in Sooke, B.C.

An ad to help with our costs